Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionGluskin Sheff & Assoc Inc
Latest Disclosed Ownership41,275 shares
Latest Disclosed Value $ 4,237,704
Gluskin Sheff & Assoc Inc reports 4.01% decrease in ownership of ABL / Abbott Laboratories

On May 15, 2026 - Gluskin Sheff & Assoc Inc filed a 13F-HR form disclosing ownership of 41,275 shares of Abbott Laboratories (DE:ABL) valued at $3,666,045 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 43,001 shares of Abbott Laboratories. This represents a change in shares of -4.01% during the quarter. The current value of the position is $3,104,706 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 41,275 -1,726 -4.01 4,238 -21.35 0.7049
2026-02-13 2025-12-31 13F ABBOTT LABS COM 002824100 43,001 -2,664 -5.83 5,388 -11.92 0.7478
2025-11-14 2025-09-30 13F ABBOTT LABS COM 002824100 45,665 -1,191 -2.54 6,116 -4.02 0.7727
2025-08-14 2025-06-30 13F ABBOTT LABS COM 002824100 46,856 -976 -2.04 6,373 0.44 0.7771
2025-05-15 2025-03-31 13F ABBOTT LABS COM 002824100 47,832 -135 -0.28 6,345 16.94 0.8174
2025-02-14 2024-12-31 13F ABBOTT LABS COM 002824100 47,967 0 0.00 5,426 -0.79 0.6504
2024-11-14 2024-09-30 13F ABBOTT LABS COM 002824100 47,967 13,986 41.16 5,469 54.90 0.6399
2024-08-14 2024-06-30 13F ABBOTT LABS COM 002824100 33,981 533 1.59 3,531 -7.13 0.4023
2024-05-15 2024-03-31 13F ABBOTT LABS COM 002824100 33,448 -2,853 -7.86 3,802 -4.86 0.3799
2024-02-14 2023-12-31 13F ABBOTT LABS COM 002824100 36,301 -11,061 -23.35 3,996 -12.91 0.3941
2023-11-14 2023-09-30 13F ABBOTT LABS COM 002824100 47,362 -3,865 -7.54 4,587 -17.85 0.3514
2023-08-14 2023-06-30 13F ABBOTT LABS COM 002824100 51,227 -4,184 -7.55 5,585 -0.46 0.3381
2023-05-15 2023-03-31 13F ABBOTT LABS COM 002824100 55,411 -4,098 -6.89 5,611 -14.13 0.3057
2023-02-14 2022-12-31 13F ABBOTT LABS COM 002824100 59,509 -22,576 -27.50 6,533 -17.75 0.3667
2022-11-14 2022-09-30 13F ABBOTT LABS COM 002824100 82,085 2,680 3.38 7,943 -7.93 0.4738
2022-08-15 2022-06-30 13F ABBOTT LABS COM 002824100 79,405 -847 -1.06 8,627 -9.18 0.4710
2022-05-16 2022-03-31 13F ABBOTT LABS COM 002824100 80,252 12,703 18.81 9,499 -0.08 0.4135
2022-02-14 2021-12-31 13F ABBOTT LABS COM 002824100 67,549 20,402 43.27 9,507 70.71 0.3898
2021-11-12 2021-09-30 13F ABBOTT LABS COM 002824100 47,147 67 0.14 5,569 2.03 0.2329
2021-08-13 2021-06-30 13F ABBOTT LABS COM 002824100 47,080 490 1.05 5,458 -2.24 0.2519
2021-05-14 2021-03-31 13F ABBOTT LABS COM 002824100 46,590 627 1.36 5,583 10.95 0.2506
2021-02-16 2020-12-31 13F ABBOTT LABS COM 002824100 45,963 -503 -1.08 5,032 -0.49 0.3451
2020-11-12 2020-09-30 13F ABBOTT LABS COM 002824100 46,466 -21,982 -32.11 5,057 -19.20 0.3316
2020-08-11 2020-06-30 13F ABBOTT LABS COM 002824100 68,448 -27,956 -29.00 6,259 -17.72 0.4170
2020-05-13 2020-03-31 13F ABBOTT LABS COM 002824100 96,404 6,344 7.04 7,607 -0.73 0.5037
2020-02-12 2019-12-31 13F ABBOTT LABS COM 002824100 90,060 -204 -0.23 7,663 1.47 0.4348
2019-11-08 2019-09-30 13F ABBOTT LABS COM 002824100 90,264 58,287 182.28 7,552 180.85 0.4722
2019-08-14 2019-06-30 13F ABBOTT LABS COM 002824100 31,977 -4,369 -12.02 2,689 -7.44 0.1610
2019-05-10 2019-03-31 13F ABBOTT LABS COM 002824100 36,346 -12,469 -25.54 2,905 -17.73 0.1723
2019-02-12 2018-12-31 13F ABBOTT LABS COM 002824100 48,815 48,815 3,531 0.2283
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.